Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
03/03/2009 | US7498436 Substituted hydroxyethylamines |
03/03/2009 | US7498328 Derivatives of sulphonamides, their preparation and use as medicaments |
03/03/2009 | US7498327 Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands |
02/26/2009 | WO2009026248A2 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
02/26/2009 | WO2009025265A1 Piperazine derivative |
02/26/2009 | WO2009024997A1 Stable amorphous form of carvedilol dihydrogen phosphate with stabilizer |
02/26/2009 | WO2009024492A1 Leukotriene b4 inhibitors |
02/26/2009 | WO2009024016A1 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl -propyl)-6,7-dihydro -1h- pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors |
02/26/2009 | WO2008138551A3 3-(2-alkoxy-phenyl)-substituted tetramates |
02/26/2009 | US20090054652 Cyanine Compound and Optical Recording Material |
02/26/2009 | US20090054649 Bridged Organosilane and Production Method Thereof |
02/26/2009 | US20090054648 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
02/26/2009 | US20090054511 S)-(+)-N-acetyl-2,4,6-tribromo-5-methoxytryptophan methyl ester (4) from (S)-(+)-N-acetyl-5-methoxytryptophan methyl ester; osteoporosis, osteoblast activator |
02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
02/26/2009 | US20090054459 Substituted indoles |
02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
02/26/2009 | US20090054407 such as 4-Methanesulfonyloxy-5-methoxy-7-[1H-5-(methylaminomethyl)indol-2-yl]isoindolinone, having an antitumor activity |
02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
02/26/2009 | US20090054401 Substituted bicyclic derivatives and use thereof |
02/26/2009 | US20090054303 Crystal forms of saxagliptin and processes for preparing same |
02/26/2009 | US20090054235 Benzoheterocyclylethylbenzamide derivatives |
02/26/2009 | US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers |
02/26/2009 | CA2696967A1 Leukotriene b4 inhibitors |
02/26/2009 | CA2694380A1 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl -propyl)-6,7-dihydro -1h- pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors |
02/25/2009 | EP2027117A2 Process for preparing 7-(acryloyl)-indoles |
02/25/2009 | EP2027088A2 Compounds for the treatment of spinal muscular atrophy and other uses |
02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
02/25/2009 | EP1885695B1 Indoline compounds |
02/25/2009 | EP1650235B1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
02/25/2009 | EP1534675B1 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists |
02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
02/25/2009 | CN101374825A Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
02/25/2009 | CN101374809A Anthraquinone derivatives as markers for liquids |
02/25/2009 | CN101374808A Indole sulfonamide modulators of progesterone receptors |
02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
02/25/2009 | CN101372473A Preparation of N-hydroxy diimide |
02/25/2009 | CN100463903C Method for preparing (s)-indoline-2-carboxylic acid and (s)-indoline-2-carboxylic acid methyl ester using hydrolytic enzyme |
02/24/2009 | US7495112 Isoindoline compounds and methods of making and using the same |
02/24/2009 | US7495111 Compounds useful as serotonin inhibitors and 5-HT1A agonists and antagonists |
02/24/2009 | US7495109 Nociceptin analogs |
02/24/2009 | US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone |
02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
02/24/2009 | CA2373962C Immediate release medicinal compositions for oral use |
02/24/2009 | CA2343088C Transfer hydrogenation process |
02/19/2009 | WO2009023677A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
02/19/2009 | WO2009022104A1 Fascaplysin derivatives and their use in the treatment of cancer |
02/19/2009 | WO2009021980A1 α-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS |
02/19/2009 | US20090048326 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
02/19/2009 | US20090048303 Indole-2-carboxamidine derivatives as nmda receptor antago |
02/19/2009 | US20090048236 New phenylalanine derivatives |
02/19/2009 | US20090048224 Compounds and methods of use |
02/19/2009 | US20090047354 process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate |
02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
02/19/2009 | US20090045730 Organic electroluminescence device and material for organic electroluminescence device |
02/19/2009 | CA2696012A1 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
02/18/2009 | EP2025669A1 Alpha-alkyl substituted N-acyltryptophanols |
02/18/2009 | EP2024341A2 Novel process for statins and its pharmaceutically acceptable salts thereof |
02/18/2009 | EP2024310A1 Materials for organic electroluminescent devices |
02/18/2009 | EP1861368B1 Process for the preparation of 2-azabicycloý3.3.0¨octane-3-carboxylic acid derivatives |
02/18/2009 | EP1658068B1 Novel cycloalkyl[b] condensed indoles |
02/18/2009 | EP1554235B1 Process for synthesizing l-y-methylene glutamic acid and analogs |
02/18/2009 | EP1377548B1 Process for nitrating photocleavable compounds |
02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
02/18/2009 | EP1017674B1 Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides |
02/18/2009 | CN101370875A Optical recording medium and azo metal chelate compound |
02/18/2009 | CN101370775A Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors |
02/18/2009 | CN101370772A Diketooxime ester compound and use thereof |
02/18/2009 | CN101366714A Acetylene derivatives having mGluR5 antagonistic activity |
02/18/2009 | CN100462356C Microwave synthesis process of 3-substituted phenyl indole compound |
02/17/2009 | US7491831 PPAR active compounds |
02/17/2009 | US7491744 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
02/13/2009 | CA2597193A1 Compounds and uses |
02/12/2009 | WO2009021114A1 PREPARATION OF SYNTHETIC NUCLEOSIDES VIA π-ALLYL TRANSITION METAL COMPLEX FORMATION |
02/12/2009 | WO2009020234A2 Pyrrolidin-2 -one derivatives as androgen receptor modulator |
02/12/2009 | WO2009019561A2 Process for preparing chiral compounds |
02/12/2009 | WO2009019508A1 Calcium ion channel modulators & uses thereof |
02/12/2009 | WO2009019281A1 Benzoisoindole derivatives and their use as ep4 receptor agonists for the treatment of pain |
02/12/2009 | WO2009019173A1 Oxime ester photoinitiators |
02/12/2009 | WO2009018662A1 Renin inhibitors |
02/12/2009 | WO2009000909A8 Salts of perindopril |
02/12/2009 | WO2008155594A3 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
02/12/2009 | WO2008155593A3 Phthalimide derivatives for labeling lipid droplets, and a method for visualization of cells and/or cellular organelles |
02/12/2009 | WO2008155421A3 Indolin-2-ones and aza-indolin-2-ones |
02/12/2009 | WO2008148755A3 Novel 5-substituted hydantoins |
02/12/2009 | US20090043112 enantiomerically enriched chiral ortho-X-substituted phenylalanine compound, wherein X is a leaving group, is subjected to cyclization, preferably at a temperature of below about 140 degrees C., upon formation of the enantiomerically enriched indoline-2-carboxylic acid compound |
02/12/2009 | US20090043111 Novel process for ropinirole preparation |
02/12/2009 | US20090043110 Asymmetric Reduction Method |
02/12/2009 | US20090043109 Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source |
02/12/2009 | US20090043108 reacting dicholoro-o-xylene with Sodium hydroxymethanesulfinate in dimethylsulfoxide solvent in presence of NaI and K2CO3 base to form sultine, reacting sultine with maleic anhydride to form tetrahydronaphthalic anhydride as a Diels-Alder adduct, aprecursor for naphthalocyanine via benzisoindolenine |
02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
02/12/2009 | US20090042967 androgen receptor modulators; specific pyrrolidinone-functional benzonitrile compounds such as 2-Chloro-4-[4-hydroxy-5-methyl-2-oxopyrrolidin-1-yl]benzonitrile or 2-Chloro-4-[5-ethyl-3,3-difluoro-4-hydroxy-2-oxopyrrolidin-1-yl]benzonitrile |
02/12/2009 | US20090042949 Indoles Useful in the Treatment of Inflammation |
02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |